Check our new article entitled “Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE” in Rheumatology (Oxford).
Check our new article entitled “Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE” in Rheumatology (Oxford).
Ioannis Parodis
Center for Molecular Medicine
Karolinska University Hospital Solna
Visionsgatan 18
SE-171 76 Stockholm
Innovative Health Initiative (IHI)
EFPIA
Karolinska Institutet
Region Stockholm
Svensk Reumatologisk Förening
Reumatikerfonden
Konung Gustaf V:s 80-årsfond
Svenska Läkaresällskapet
Nyckelfonden
Professor Nanna Svartz fond
Ulla och Roland Gustafssons donationsfond
Roche
GlaxoSmithKline (GSK)
Bristol-Myers Squibb (BMS)
Aurinia
Otsuka
© 2024 Parodis lab. All Rights Reserved. Developed by Pixelware